Loader
We have noticed an unusual activity from your IP 199.16.157.180 and blocked access to this
We have noticed an unusual activity from your IP 199.16.157.180 and blocked access to this
The FDA has approved trastuzumab-strf (Hercessi), a biosimilar to trastuzumab (Herceptin), for the treatment of HER2-overexpressing breast cancer and gastric or gastroesophageal junction adenocarcinom…
At the Great Debates and Updates in Lung Cancer Meeting in New York, New York, Jamie Chaft, MD, argued in favor of both pre- and…
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of…
Introduction During the CAR-T & Bispecifics Conference, Dr. Brian Sworder, MD, from UCI Irvine, shared compelling insights on the utility of circulating
R. Lor Randall, MD, FACS, discusses research examining ALDH1A1 and CD44, potential markers of osteosarcoma stem cells, and how further research may be warranted with…
Can AI-enabled technology safeguard hospitals, pharmacies, and medical devices from cyberattacks? To access this subscriber-only content please log in or renew your subscription.Looking for IP…
Moffitt Cancer Center takes a multispecialty approach to testicular cancer treatment. Learn more about this type of cancer and its treatment options here.
While window glass blocks most UVB rays, the ones that can burn you, UVA rays, which can cause tanning and premature aging, still get through.
The American Urological Association (AUA), in partnership with ASCO and the Society of Urologic Oncology (SUO), has issued a 2024 clinical practice guideline amendment for…
Introduction During the recent CAR-T & Bispecifics conference, Dr. Nitin Jain, MD, from MD Anderson Cancer Center in Houston, Texas, presented a challeng